278 related articles for article (PubMed ID: 11768328)
21. Novel molecular targets for antimalarial chemotherapy.
Jana S; Paliwal J
Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
[TBL] [Abstract][Full Text] [Related]
22. The apicoplast: a plastid in Plasmodium falciparum and other Apicomplexan parasites.
Foth BJ; McFadden GI
Int Rev Cytol; 2003; 224():57-110. PubMed ID: 12722949
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium falciparum apicoplast drugs: targets or off-targets?
Botté CY; Dubar F; McFadden GI; Maréchal E; Biot C
Chem Rev; 2012 Mar; 112(3):1269-83. PubMed ID: 22026508
[No Abstract] [Full Text] [Related]
24. Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.
Uddin T; McFadden GI; Goodman CD
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109165
[TBL] [Abstract][Full Text] [Related]
25. A systematic in silico search for target similarity identifies several approved drugs with potential activity against the Plasmodium falciparum apicoplast.
Bispo NA; Culleton R; Silva LA; Cravo P
PLoS One; 2013; 8(3):e59288. PubMed ID: 23555651
[TBL] [Abstract][Full Text] [Related]
26. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
Bustamante C; Batista CN; Zalis M
Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
[TBL] [Abstract][Full Text] [Related]
27. The apicoplast of Plasmodium falciparum is translationally active.
Chaubey S; Kumar A; Singh D; Habib S
Mol Microbiol; 2005 Apr; 56(1):81-9. PubMed ID: 15773980
[TBL] [Abstract][Full Text] [Related]
28. Is chemical genetics the new frontier for malaria biology?
Greenbaum DC
Trends Pharmacol Sci; 2008 Feb; 29(2):51-6. PubMed ID: 18199489
[TBL] [Abstract][Full Text] [Related]
29. Drug resistant falciparum malaria: clinical consequences and strategies for prevention.
Price RN; Nosten F
Drug Resist Updat; 2001 Jun; 4(3):187-96. PubMed ID: 11768332
[TBL] [Abstract][Full Text] [Related]
30. Antimalarial drugs - host targets (re)visited.
Cunha-Rodrigues M; Prudêncio M; Mota MM; Haas W
Biotechnol J; 2006 Mar; 1(3):321-32. PubMed ID: 16897712
[TBL] [Abstract][Full Text] [Related]
31. New proteins in the apicoplast membranes: time to rethink apicoplast protein targeting.
Lim L; Kalanon M; McFadden GI
Trends Parasitol; 2009 May; 25(5):197-200. PubMed ID: 19346163
[TBL] [Abstract][Full Text] [Related]
32. A novel transporter, Pfcrt, confers antimalarial drug resistance.
Howard EM; Zhang H; Roepe PD
J Membr Biol; 2002 Nov; 190(1):1-8. PubMed ID: 12422267
[TBL] [Abstract][Full Text] [Related]
33. The development of the antimalarial drugs with new type of chemical structure--qinghaosu and dihydroqinghaosu.
Tu Y
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):250-1. PubMed ID: 15691118
[No Abstract] [Full Text] [Related]
34. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
[TBL] [Abstract][Full Text] [Related]
35. The carbon and energy sources of the non-photosynthetic plastid in the malaria parasite.
Lim L; Linka M; Mullin KA; Weber AP; McFadden GI
FEBS Lett; 2010 Feb; 584(3):549-54. PubMed ID: 19968990
[TBL] [Abstract][Full Text] [Related]
36. The malaria parasite Plasmodium falciparum has only one pyruvate dehydrogenase complex, which is located in the apicoplast.
Foth BJ; Stimmler LM; Handman E; Crabb BS; Hodder AN; McFadden GI
Mol Microbiol; 2005 Jan; 55(1):39-53. PubMed ID: 15612915
[TBL] [Abstract][Full Text] [Related]
37. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
38. Spread and evolution of Plasmodium falciparum drug resistance.
Mita T; Tanabe K; Kita K
Parasitol Int; 2009 Sep; 58(3):201-9. PubMed ID: 19393762
[TBL] [Abstract][Full Text] [Related]
39. A histidine-rich protein 2-based malaria drug sensitivity assay for field use.
Noedl H; Attlmayr B; Wernsdorfer WH; Kollaritsch H; Miller RS
Am J Trop Med Hyg; 2004 Dec; 71(6):711-4. PubMed ID: 15642959
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.
Hoen R; Novoa EM; López A; Camacho N; Cubells L; Vieira P; Santos M; Marin-Garcia P; Bautista JM; Cortés A; Ribas de Pouplana L; Royo M
Chembiochem; 2013 Mar; 14(4):499-509. PubMed ID: 23444099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
